Sir Shankar Balasubramanian
Professor Sir Shankar Balasubramanian (together with Sir David Klenerman) have been awarded the 2020 Millenium Technology Prize “their innovation of Next Generation DNA Sequencing (NGS), technology that enables fast, accurate, low-cost and large-scale genome sequencing”. Sir Shankar is the Herchel Smith Professor of Medicinal Chemistry at the University of Cambridge and Trinity Fellow.
Professor Sir Shankar Balasubramanian (together with Sir David Klenerman and Pascal Mayer) were awarded the 2022 Breakthrough Prize in Life Sciences
Sir Shankar is the scientific founder of two companies:
- Solexa: https://www.ch.cam.ac.uk/collaboration-and-impact/solexa-sequencing
- Cambridge Epigenetix https://cambridge-epigenetix.com/
Trinity in Japan
Chair and Founder: Gerhard Fasol